BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul type="disc"><li>
Hawkins (HWKN) has leveraged its storage capabilities to meet increased demand for specialty chemicals at a time when demand has increased. HWKN reported fiscal first quarter (June) results surpassing our expectations on the heels of higher pricing and volumes for multiple products.</li></ul> <ul type="disc"><li>Ahead of the results we had been expecting some normalization in HWKN’s business due to loosened COVID-19 restrictions. Even though there was evidence of lower bleach demand, there was an increase across a multitude of the products HWKN sells, including those where there has been material increase in selling prices.</li></ul> <ul type="disc"><li>HWKN reported revenue of $181.2 million compared to our estimate of $178.8 million. The increase in revenue was the result of higher industrial and water treatment revenue while health &amp; nutrition revenue declined sequentially faster than we had expected.</li></ul> <ul type="disc"><li>We are making changes to our earnings model to reflect the improvement in the underlying demand in HWKN’s businesses. This includes using a higher gross margin than we had originally modeled at the start of the fiscal year.</li></ul>


Hawkins (HWKN) has leveraged its storage capabilities to meet increased demand for specialty chemicals at a time when demand has increased. HWKN reported fiscal first quarter (June) results surpassing our expectations on the heels of higher pricing and volumes for multiple products. Ahead of the results we had been expecting some normalization in HWKN’s business due to loosened COVID-19 restrictions. Even though there was evidence of lower bleach demand, there was an increase across a multitude of the products HWKN sells, including those where there has been material increase in selling prices. HWKN reported revenue of $181.2 million compared to our estimate of $178.8 million. The increase in revenue was the result of higher industrial and water treatment revenue while health &amp; nutrition revenue declined sequentially faster than we had expected. We are making changes to our earnings model to reflect the improvement in the underlying demand in HWKN’s businesses. This includes using a higher gross margin than we had originally modeled at the start of the fiscal year.

Hawkins Inc

HWKN: The Right Ingredients